Sunday, September 30, 2018

New cancer vaccine shows early promise for patients with HER2-positive cancers

Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial.

from Latest Science News -- ScienceDaily https://ift.tt/2RfNc8m
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden stem cells may be fueling spinal stenosis

Scientists have discovered a stem cell that appears to serve as a master source for tendon and ligament cells throughout the body. In lumbar...